Please Wait
Applying Filters...
menu
    • menu
    How Trump’s tariffs on imported drugs can hurt supply chains, consumers and industry

    Data Compilation
    #PharmaFlow

    Pipeline Prospector March 2025: Trump’s FDA overhaul spooks biotech stocks; Roche, AbbVie, Novo ink obesity drug deals

    Stock Recap
    #PipelineProspector

    Menu

    Urea, N-(4-(1-((2,6-difluorophenyl)methyl)-5-((dimethylamino)methyl)-1,2,3,4-tetrahydro-3-(6-methoxy-3-pyridazinyl)-2,4-dioxothieno(2,3-d)pyrimidin-6-yl)phenyl)-N'-methoxy-

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 7,497Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to access your PharmaMiles and download the data

    Last Updated on PharmaCompass Virtual Booth Country Labeler NDC Package Code Non Proprietary Name Start Marketing Date End Marketing Date Category Code Dosage Form (Strength)
    28/03/2025 BDR Lifesciences
    India
    		 BDR Lifesciences Private Limited 76361-0004 Relugolix 2024-04-01 2025-12-31 BULK INGREDIENT POWDER (1kg/kg)
    28/03/2025 Fareva
    Luxembourg
    		 Excella GmbH & Co. KG 46014-1130 Relugolix 2020-12-18 2025-12-31 BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING POWDER (1kg/kg)